Terug
Dagbereik
€ 105,47
€ 108,50
52-Weeksbereik
€ 100,18
€ 143,32
Volume
634.933
50D / 200D Gem.
€ 108,90
/
€ 118,14
Vorige Slotkoers
€ 105,41
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -5,2 | 0,4 |
| P/B | 1,5 | 2,9 |
| ROE % | -24,5 | 3,7 |
| Net Margin % | -45,5 | 3,9 |
| Rev Growth 5Y % | -8,2 | 10,0 |
| D/E | 0,9 | 0,2 |
Koersdoel Analisten
Hold
€ 133,25
+25.9%
Low: € 116,00
High: € 147,00
Forward K/W
14,3
Forward WPA
€ 7,43
WPA Groei (sch.)
+0,0%
Omzet Sch.
2,4 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 11,07
€ 11,00 – € 11,17
|
2,8 B | 1 |
| FY2029 |
€ 10,04
€ 9,97 – € 10,13
|
2,7 B | 1 |
| FY2028 |
€ 11,76
€ 11,68 – € 11,86
|
2,5 B | 1 |
Belangrijkste Punten
Revenue declined -8,23% annually over 5 years
Earnings declined -1399,81% over the past year
Generating 245,44M in free cash flow
PEG of 0,00 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 26,38%
Capital efficient — spends only 4,78% of revenue on capex
Groei
Revenue Growth (5Y)
-8,23%
Revenue (1Y)-34,61%
Earnings (1Y)-1399,81%
FCF Growth (3Y)-23,48%
Kwaliteit
Return on Equity
-24,47%
ROIC3,28%
Net Margin-45,45%
Op. Margin12,84%
Veiligheid
Debt / Equity
0,87
Current Ratio2,54
Interest Coverage2,55
Waardering
P/E Ratio
-5,17
P/B Ratio1,50
EV/EBITDA27,41
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -34,61% | Revenue Growth (3Y) | -18,15% |
| Earnings Growth (1Y) | -1399,81% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -8,23% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,99B | Net Income (TTM) | -905,64M |
| ROE | -24,47% | ROA | -13,04% |
| Gross Margin | 56,24% | Operating Margin | 12,84% |
| Net Margin | -45,45% | Free Cash Flow (TTM) | 245,44M |
| ROIC | 3,28% | FCF Growth (3Y) | -23,48% |
| Safety | |||
| Debt / Equity | 0,87 | Current Ratio | 2,54 |
| Interest Coverage | 2,55 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | -5,17 | P/B Ratio | 1,50 |
| P/S Ratio | 2,35 | PEG Ratio | 0,00 |
| EV/EBITDA | 27,41 | Dividend Yield | 0,01% |
| Market Cap | 4,68B | Enterprise Value | 7,01B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,99B | 3,05B | 2,97B | 2,79B | 2,81B |
| Net Income | -905,64M | 69,68M | 356,33M | 363,14M | 485,37M |
| EPS (Diluted) | -20,25 | 1,48 | 7,53 | 7,68 | 10,23 |
| Gross Profit | 1,12B | 1,70B | 1,65B | 1,53B | 1,55B |
| Operating Income | 255,80M | 151,01M | 506,31M | 499,73M | 628,10M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6,95B | 7,10B | 7,53B | 6,93B | 6,87B |
| Total Liabilities | 3,82B | 2,82B | 3,09B | 2,91B | 3,12B |
| Shareholders' Equity | 3,12B | 4,28B | 4,44B | 4,02B | 3,75B |
| Total Debt | 2,73B | 1,76B | 1,93B | 1,83B | 1,97B |
| Cash & Equivalents | 393,26M | 290,19M | 222,85M | 292,03M | 445,08M |
| Current Assets | 1,94B | 1,47B | 1,41B | 1,41B | 1,43B |
| Current Liabilities | 762,03M | 649,36M | 606,75M | 581,49M | 680,12M |